Bajaj Healthcare Limited — Others, 11-02-2025: Monitoring Agency Report

Bajaj Healthcare Limited has announced a board meeting to discuss the Monitoring Agency Report for the quarter ended December 31, 2024. The report confirms that the utilization of proceeds from the recent preferential issue of equity shares and convertible warrants, raising ₹204.97 crore, aligns with the stated objectives. There were no deviations noted, and the allocation for general corporate purposes was revised slightly downward to ₹19.97 crore due to the undersubscribed issue. This strong regulatory compliance could bolster investor confidence and signal prudent management practices, while the timely utilization of funds supports operational stability. A positive outlook for the company's financial health is evident.